LIPASE LIP2

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	2

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003831-31-ES (EUCTR)	24/01/2020	02/12/2019	MS1819-SD phase II clinical trial for Exocrine Pancreatic Insufficiency caused by Cystic Fibrosis.	A multicenter, open-label Phase 2 study with escalating doses of MS1819-SD on top of a stable dose o ...	Exocrine Pancreatic Insufficiency MedDRA version: 20.0;Level: LLT;Classification code 10033628;Term: ...	Product Name: MS1819-SD INN or Proposed INN: Lipase Lip2from Yarrowia lipolytica Other descriptive nam ...	AzurRx	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Hungary;Poland;Spain
2	EUCTR2018-003831-31-PL (EUCTR)		01/12/2020	MS1819-SD phase II clinical trial for Exocrine Pancreatic Insufficiency caused by Cystic Fibrosis.	A multicenter, open-label Phase 2 study with escalating doses of MS1819-SD on top of a stable dose o ...	Exocrine Pancreatic Insufficiency due to Cystic Fibrosis MedDRA version: 20.0;Level: LLT;Classificat ...	Product Name: MS1819-SD INN or Proposed INN: Lipase Lip2from Yarrowia lipolytica Other descriptive nam ...	AzurRx SAS	NULL	Not Recruiting			Female: yes Male: yes	24	Phase 2	Hungary;Spain;Poland;Turkey

First Previous1Next Last